Bill > HB5682

This bill establishes the West Virginia Prescription Drug Affordability Board and Prescription Drug Affordability Stakeholder Council to protect West Virginia residents, governments, health plans, providers, and other stakeholders from high prescription drug costs. The board will collect and review data on prescription drug prices, identify drugs that may create affordability challenges, and conduct cost reviews to determine if those drugs should have upper payment limits set. The board is funded through an annual fee on manufacturers, pharmacy benefit managers, insurers, and wholesale distributors. The bill also requires the board to study the pharmaceutical system and make recommendations on further legislation to improve drug affordability in the state.